Ebselen, a new candidate therapeutic against SARS-CoV-2
| Errataetall: | |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:84 |
|---|---|
| Enthalten in: |
International journal of surgery (London, England) - 84(2020) vom: 01. Dez., Seite 53-56 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Haritha, C V [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
40X2P7DPGH |
|---|
| Anmerkungen: |
Date Completed 01.01.2021 Date Revised 04.12.2021 published: Print-Electronic CommentOn: Int J Surg. 2020 Jul;79:143-153. - PMID 32422384 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.ijsu.2020.10.018 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM316887366 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM316887366 | ||
| 003 | DE-627 | ||
| 005 | 20231225162044.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ijsu.2020.10.018 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1056.xml |
| 035 | |a (DE-627)NLM316887366 | ||
| 035 | |a (NLM)33120196 | ||
| 035 | |a (PII)S1743-9191(20)30755-X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Haritha, C V |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Ebselen, a new candidate therapeutic against SARS-CoV-2 |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 01.01.2021 | ||
| 500 | |a Date Revised 04.12.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: Int J Surg. 2020 Jul;79:143-153. - PMID 32422384 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Clinical trials | |
| 650 | 4 | |a Ebselen | |
| 650 | 4 | |a Main protease | |
| 650 | 4 | |a Repurposed drug | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a Therapeutics | |
| 650 | 7 | |a Azoles |2 NLM | |
| 650 | 7 | |a Isoindoles |2 NLM | |
| 650 | 7 | |a Organoselenium Compounds |2 NLM | |
| 650 | 7 | |a ebselen |2 NLM | |
| 650 | 7 | |a 40X2P7DPGH |2 NLM | |
| 700 | 1 | |a Sharun, Khan |e verfasserin |4 aut | |
| 700 | 1 | |a Jose, Bosco |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International journal of surgery (London, England) |d 2004 |g 84(2020) vom: 01. Dez., Seite 53-56 |w (DE-627)NLM169227847 |x 1743-9159 |7 nnns |
| 773 | 1 | 8 | |g volume:84 |g year:2020 |g day:01 |g month:12 |g pages:53-56 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ijsu.2020.10.018 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 84 |j 2020 |b 01 |c 12 |h 53-56 | ||